Literature DB >> 20379169

Biotech in a blink.

Ken Garber.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20379169     DOI： 10.1038/nbt0410-311

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  7 in total

1.  Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.

Authors:  Bao-Yang Hu; Jason P Weick; Junying Yu; Li-Xiang Ma; Xiao-Qing Zhang; James A Thomson; Su-Chun Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

2.  Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization.

Authors:  Nobuo Jo; Carolina Mailhos; Meihua Ju; Eunice Cheung; John Bradley; Kazuaki Nishijima; Gregory S Robinson; Anthony P Adamis; David T Shima
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

3.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Authors:  David M Brown; Peter K Kaiser; Mark Michels; Gisele Soubrane; Jeffrey S Heier; Robert Y Kim; Judy P Sy; Susan Schneider
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

4.  Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Authors:  Kazuaki Nishijima; Yin-Shan Ng; Lichun Zhong; John Bradley; William Schubert; Nobuo Jo; Jo Akita; Steven J Samuelsson; Gregory S Robinson; Anthony P Adamis; David T Shima
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

5.  Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.

Authors:  Albert M Maguire; Katherine A High; Alberto Auricchio; J Fraser Wright; Eric A Pierce; Francesco Testa; Federico Mingozzi; Jeannette L Bennicelli; Gui-shuang Ying; Settimio Rossi; Ann Fulton; Kathleen A Marshall; Sandro Banfi; Daniel C Chung; Jessica I W Morgan; Bernd Hauck; Olga Zelenaia; Xiaosong Zhu; Leslie Raffini; Frauke Coppieters; Elfride De Baere; Kenneth S Shindler; Nicholas J Volpe; Enrico M Surace; Carmela Acerra; Arkady Lyubarsky; T Michael Redmond; Edwin Stone; Junwei Sun; Jennifer Wellman McDonnell; Bart P Leroy; Francesca Simonelli; Jean Bennett
Journal:  Lancet       Date:  2009-10-23       Impact factor: 79.321

6.  Regulation of adult hematopoietic stem cells fate for enhanced tissue-specific repair.

Authors:  Nilanjana Sengupta; Sergio Caballero; Sean M Sullivan; Lung-Ji Chang; Aqeela Afzal; Sergio Li Calzi; Jennifer L Kielczewski; Sabrina Prabarakan; E Ann Ellis; Leni Moldovan; Nicanor I Moldovan; Michael E Boulton; Maria B Grant; Edward W Scott; Jeffrey R Harris
Journal:  Mol Ther       Date:  2009-07-07       Impact factor: 11.454

7.  Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration.

Authors:  Bin Lu; Christopher Malcuit; Shaomei Wang; Sergej Girman; Peter Francis; Linda Lemieux; Robert Lanza; Raymond Lund
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277
  7 in total
  6 in total

1.  Companies in footrace to deliver RNAi.

Authors:  Aaron Bouchie
Journal:  Nat Biotechnol       Date:  2012-12       Impact factor: 54.908

2.  Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells.

Authors:  Wan Wang; Parameswaran G Sreekumar; Vinod Valluripalli; Pu Shi; Jiawei Wang; Yi-An Lin; Honggang Cui; Ram Kannan; David R Hinton; J Andrew MacKay
Journal:  J Control Release       Date:  2014-04-26       Impact factor: 9.776

Review 3.  Adult neural stem cells: response to stroke injury and potential for therapeutic applications.

Authors:  Basam Z Barkho; Xinyu Zhao
Journal:  Curr Stem Cell Res Ther       Date:  2011-12       Impact factor: 3.828

4.  A thermo-responsive protein treatment for dry eyes.

Authors:  Wan Wang; Aarti Jashnani; Suhaas R Aluri; Joshua A Gustafson; Pang-Yu Hsueh; Frances Yarber; Robert L McKown; Gordon W Laurie; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  J Control Release       Date:  2014-12-03       Impact factor: 9.776

5.  Broad spectrum antiangiogenic treatment for ocular neovascular diseases.

Authors:  Ofra Benny; Kei Nakai; Takeru Yoshimura; Lauren Bazinet; James D Akula; Shintaro Nakao; Ali Hafezi-Moghadam; Dipak Panigrahy; Pouya Pakneshan; Robert J D'Amato
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

6.  Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice.

Authors:  Alina Adriana Ivanescu; Patricia Fernández-Robredo; Henar Heras-Mulero; Luis Manuel Sádaba-Echarri; Laura García-García; Vanessa Fernández-García; Maite Moreno-Orduna; Aitor Redondo-Exposito; Sergio Recalde; Alfredo García-Layana
Journal:  Nutrients       Date:  2015-07-06       Impact factor: 5.717
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.